Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter
Authors:
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 434, 115823
Abstract
No abstract availableKeywords
Funding Information
- Univerzita Karlova v Praze (SVV/2021/260 549)
- Grantová Agentura České Republiky (20-20414Y)
- European Regional Development Fund (85009748)
This publication has 55 references indexed in Scilit:
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer CellsJournal of Biological Chemistry, 2010
- Transplacental Pharmacokinetics of Glyburide, Rhodamine 123, and BODIPY FL Prazosin: Effect of Drug Efflux Transporters and Lipid SolubilityThe Journal of Pharmacology and Experimental Therapeutics, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- ABC transporters: the power to changeNature Reviews Molecular Cell Biology, 2009
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Multidrug Transporter ABCG2 Prevents Tumor Cell Death Induced by the Epidermal Growth Factor Receptor Inhibitor Iressa (ZD1839, Gefitinib)Cancer Research, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- The Protein Data BankNucleic Acids Research, 2000